Clinical Trials
37 trialsOPTI-DOSE
University Medical Center Groningen
Application Circulating Tumor DNA Dynamic Monitoring in Clinical Treatment of Metastatic Renal Cell Carcinoma
RenJi Hospital
SURF
Centre Hospitalier Universitaire de Besancon
Style
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
STELLAR
Amsterdam UMC, location VUmc
SUNRISE-CRC
Amsterdam UMC, location VUmc
HGG-TCP (High Grade Glioma - Tumor Concentrations of Protein Kinase Inhibitors)
Amsterdam UMC, location VUmc
COMBOREIN
University Hospital, Grenoble
SuAx
Instituto do Cancer do Estado de São Paulo
Role of Surgery in Patients With Focally Progressive Gastrointestinal Stromal Tumors (GISTs) After Imatinib Treatment
Shanghai Zhongshan Hospital
Combined Alternating Sunitinib and Bevacizumab (Avastin®) in Advanced Renal Cell Carcinoma (CASA)
King Faisal Specialist Hospital & Research Center
SUNLAND
GERCOR - Multidisciplinary Oncology Cooperative Group
QUASAR
Consorzio Oncotech
Combining Sunitinib, Temozolomide and Radiation to Treat Patients Diagnosed With Glioblastoma
McGill University Health Centre/Research Institute of the McGill University Health Centre
GITIC
Sun Yat-sen University
Randomized Study of Doxorubicin and Cyclophosphamide With or Without Intermittent Sunitinib in the First-line Treatment of Locally Advanced or Metastatic Breast Cancer Patients With Measurable Primary Breast Tumor
National University Hospital, Singapore
Docetaxel With or Without Low-dose, Short Course Sunitinib in Refractory Solid Tumors
National University Hospital, Singapore
Dose-dense Doxorubicin/Cyclophosphamide With Intermittent Low-dose Sunitinib in Breast Cancer Patients
National University Hospital, Singapore
A Phase II Trila of Sunitinib Schedule 4/2 vs. Shedule 2/1 as First Line Therapy in Metastatic Renal Cell Carcinoma.
Peking University Cancer Hospital & Institute
MORE
Heidelberg University
Sunitinib, Tamoxifen, and Cisplatin in Treating Patients With High-Risk Ocular Melanoma
National Cancer Institute (NCI)
Sunitinib Before and After Surgery in Treating Patients With Stage IV Kidney Cancer
National Cancer Institute (NCI)
Sunitinib Before or After Surgery in Treating Patients With Metastatic Kidney Cancer
National Cancer Institute (NCI)
Sunitinib Malate and Exemestane in Treating Postmenopausal Women With Breast Cancer
National Cancer Institute (NCI)
Sunitinib Malate in Treating Patients With Locally Recurrent, Locally Advanced, Unresectable, or Metastatic Urinary Tract Cancer
National Cancer Institute (NCI)
Sequential Use of Low-dose Sunitinib With Chemotherapy in Advanced NSCLC After Failure of Conventional Regimen
ChineseAMS
SMAT
Association of Urologic Oncology (AUO)
SMART
AHS Cancer Control Alberta
SUNXRT
Australasian Sarcoma Study Group
Neoadjuvant Sunitinib Treatment for Metastatic Clear Cell Renal Cell Carcinoma (RCC)
Korean Urological Oncology Society
Trial Of Sunitinib In Advanced Non-Clear Cell Type Renal Cell Carcinoma
Asan Medical Center
Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
Third Military Medical University
SURGE01-07
Medical University Innsbruck
Biomarker Study for Sunitinib and Docetaxel in Prostate Cancer
Medical University of Vienna
Salvage Therapy With Sunitinib,Docetaxel and Platinum on Metastatic or Unresectable Non Small Cell Lung Cancer
Taipei Medical University Hospital
rcc
Hadassah Medical Organization
Activity Study of Sunitinib In Metastatic Pretreated Urothelial Cancer
Campania Younger Oncologists Association